Method not sensitive enough [Study As­sess­ment]

posted by Aymanmy – Jordan, 2019-12-18 17:58 (487 d 23:28 ago) – Posting: # 21001
Views: 2,048

Hi Helmut and colleagues
thanks for your replies and interactions,
my concern is the study is already submitted by the sponsor to the H.A, and the study results are known, also the samples are out of studied long term stability, can we just exclude the results of the affected subjects from the statistics?
and plz to confirm that every individual subject should fulfil the less than 5% of Cmax criteria for the future?

thanks again very much for your inteaction, its highly appreciated.

Complete thread:

Activity
 Admin contact
21,419 posts in 4,475 threads, 1,510 registered users;
online 6 (0 registered, 6 guests [including 2 identified bots]).
Forum time: Monday 18:27 CEST (Europe/Vienna)

There is one certainty in drug development
and statistics that one can depend on:
the data are always late.    Scott Patterson and Byron Jones

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5